Condition: Heart Failure · Heart Failure - NYHA II - IV · Heart Failure Patients · Sponsor: University Health Network, Toronto
Heart Failure (HF) is a complex disease associated with the highest burden of cost to the healthcare system. The cardiopulmonary exercise test (CPET) is instrumental in determining the prognosis of patients with HF. This multicentre study will validate whether aggregate biometric data from the Apple Watch combined with demographic, cardiac, and biomarker testing can improve our ability to predict heart failure outcomes among a diverse outpatient HF population.
This description comes directly from the study's public registry record.
Ryan Li, MASc · 6479669330 · ryan.li@uhn.ca
Ben Kim, PhD · ben.kim@uhn.ca
Always discuss trial participation with your own doctor first.
| Southlake Health | Newmarket, Ontario, Canada | Not Yet Recruiting |
| 200 Elizabeth Street | Toronto, Ontario, Canada | Recruiting |
| Sunnybrook Health Sciences Center | Toronto, Ontario, Canada | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07447908